RUO urelumab是一種靶向4-1BB的人源化激動(dòng)性單克隆抗體,具有潛在的免疫刺激和抗腫瘤活性。Urelumab特異性結(jié)合并激活表達(dá)CD 137的免疫細(xì)胞,刺激針對(duì)腫瘤細(xì)胞的免疫應(yīng)答,特別是細(xì)胞毒性T細(xì)胞應(yīng)答。. Urelumab生物仿制藥-研究級(jí)該產(chǎn)品同種型對(duì)照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.